KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Short-term Investments (2017 - 2022)

Palvella Therapeutics (PVLA) has disclosed Short-term Investments for 6 consecutive years, with $9.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Short-term Investments fell 56.32% to $9.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $9.0 million, a 56.32% decrease, with the full-year FY2023 number at $9.0 million, down 56.32% from a year prior.
  • Short-term Investments was $9.0 million for Q4 2023 at Palvella Therapeutics, down from $11.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $58.7 million in Q1 2019 to a low of $8.6 million in Q1 2023.
  • A 4-year average of $26.5 million and a median of $21.4 million in 2022 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: rose 17.23% in 2019, then plummeted 62.75% in 2023.
  • Palvella Therapeutics' Short-term Investments stood at $41.9 million in 2019, then crashed by 62.41% to $15.8 million in 2020, then soared by 30.37% to $20.5 million in 2022, then tumbled by 56.32% to $9.0 million in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Short-term Investments are $9.0 million (Q4 2023), $11.9 million (Q3 2023), and $9.9 million (Q2 2023).